Aging is something we all go through. As we grow older, our bodies slowly lose their strength, and the risk of diseases increases. While aging is a natural part of life, scientists have long searched for ways to slow it down and help people live not only longer but also healthier lives.
One approach that has shown promise is caloric restriction—eating fewer calories while still getting enough nutrients. This method has been proven in animal studies to extend both lifespan (how long we live) and healthspan (the years we live without major diseases).
However, it’s not easy for most people to stick to a low-calorie diet over the long term. It can lead to hunger, fatigue, and even nutrient shortages. That’s why scientists are trying to find other ways to get the same benefits without having to cut calories.
One exciting area of research involves finding drugs that mimic the effects of caloric restriction. Some of the most well-known ones include metformin (used for diabetes), rapamycin (used to prevent organ rejection), and resveratrol (found in red wine).
These have all shown some benefits in animal studies, but they also come with challenges—such as difficult delivery methods, limited absorption in the body, or unwanted side effects.
Recently, researchers at the University of Liverpool have found a new drug that could be a better option: rilmenidine. This drug is already widely used to treat high blood pressure. In a series of studies using animals like worms, flies, and mice, scientists found that rilmenidine could help these animals live longer and stay healthier—just like caloric restriction does.
The reason rilmenidine works seems to be tied to a special receptor in the body called the I1-imidazoline receptor, also known as nischarin-1. By acting on this receptor, the drug triggers a chain of responses in the body that improve overall health and may slow the aging process. This is important because it gives scientists a clear target for developing future anti-aging drugs.
One of the biggest advantages of rilmenidine is that it’s already on the market. It comes in pill form, is easy to take, and is known to have only mild side effects.
This makes it much more convenient than other drugs being studied for aging, some of which require injections or have strong side effects. Since rilmenidine is already approved and used by many patients, it could be repurposed for anti-aging use more quickly and at a lower cost than brand-new drugs.
This discovery could have big benefits, especially as people around the world live longer. Even small delays in the aging process could lead to better health, more years free from disease, and lower healthcare costs. Using existing drugs in new ways—called drug repurposing—is a smart strategy because these medications are already known to be safe.
Of course, more research is needed to confirm these results in humans. Scientists still need to fully understand how rilmenidine works in the body and whether it can provide the same benefits in people as it does in animals. But this study is a promising first step.
In the future, common medications like rilmenidine could become powerful tools to help people age more slowly and stay healthier for longer. It’s a reminder that the answers to some of our biggest health questions might already be sitting in our medicine cabinets.
If you care about blood pressure, please read studies that black licorice could cause dangerous high blood pressure, and this common plant nutrient could help reduce high blood pressure.
For more information about blood pressure, please see recent studies about how coffee influence your risk of high blood pressure, and results showing this olive oil could reduce blood pressure in healthy people.
Copyright © 2025 Knowridge Science Report. All rights reserved.
